check_circleStudy Completed
Cardiovascular Disease, Colorectal Cancer
Bayer Identifier:
20211
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to evaluate how patients regard the benefits and risks of low-dose aspirin for the prevention of heart and blood vessels disease and for the prevention of cancer of the colon and rectum
Trial purpose
Research shows that low-dose Aspirin prevents diseases of heart and blood vessels as well as cancer of the colon and rectum and it is also associated with risk of bleeding. In this study, they want to learn how patients regard the benefits and risks of low-dose Aspirin for the prevention of these diseases. The researchers also want to learn how patients balance these risks and benefits.
Key Participants Requirements
Sex
AllAge
18 - 70 YearsTrial summary
Enrollment Goal
1028Trial Dates
August 2019 - October 2019Phase
Phase 4Could I Receive a placebo
NoProducts
Aspirin (Acetylsalicylic Acid, BAYE4465)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many locations | Many locations, Italy |
Primary Outcome
- Perceive of low dose aspirinUsing qualitative interviews to assess how patients and physicians perceive the benefits and risks of low-dose aspirin for the prevention of cardiovascular disease (CVD) and colorectal cancer (CRC)date_rangeTime Frame:Up to 1 hour
- Patients' benefit/risk trade-offsUsing quantitative surveys to elicit patients’ benefit/risk trade-offs on key efficacy and safety outcomes of low-dose aspirin in CVD and CRC preventiondate_rangeTime Frame:Up to 1 hour
Secondary Outcome
- Change in likelihood of AEsQuantify the change in likelihood of adverse events (AEs) that patients are willing to accept in order to experience the benefits of low-dose aspirin for CRC and CVD prevention compared to CVD prevention alonedate_rangeTime Frame:Up to 1 hour
- Preferences of aspirin using in different subgroupsAssess how different subgroups of patients, such as those using low-dose aspirin and those eligible for but not using low-dose aspirin, differ in their preferencesdate_rangeTime Frame:Up to 1 hour
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A